NCT03530774

Brief Summary

Older adults are at risk for developing sarcopenia, or age-related muscle loss, which increased the risk of disabilities, falls, and loss of independence. Many older adults do not consume enough protein each day to maintain their muscle mass and this study aims to investigate if consumption daily egg white protein supplement can help maintain muscle mass and functionality in community-dwelling older adults. Food insecure older adults that attend congregate nutrition sites will be targeted.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 31, 2017

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 13, 2017

Completed
7 months until next milestone

First Posted

Study publicly available on registry

May 21, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2018

Completed
Last Updated

December 20, 2024

Status Verified

November 1, 2020

Enrollment Period

1.3 years

First QC Date

October 13, 2017

Last Update Submit

December 17, 2024

Conditions

Keywords

physical performance battery24-hour dietary recallsdual-energy X-ray absorptimetrydietary supplementprotein

Outcome Measures

Primary Outcomes (3)

  • Muscle mass

    Dual-energy X-ray absorptimetry

    Change from Baseline Muscle Mass at 6 months

  • Short physical performance battery (SPPB)

    Includes objective, performance-based measures of balance (standing side by side, semi-tandem and tandem), mobility (4-m habitual gait speed), and strength (5 chair stands). Each task is scored from 0-4 Points (p) and then summed into a total score of 0 (worst)-12 (best) p, where 12 p represents the highest performance.

    Change from Baseline Physical Function at 6 months

  • Muscle Strength

    Hand Dynamometer

    Change from Baseline Muscle Strength at 6 months

Secondary Outcomes (6)

  • Protein intake

    Change from Baseline Protein Intake at 6 months

  • Health-Related Quality of Life

    Change from Baseline Health-Related Quality of Life at 6 months

  • Upper Respiratory Illnesses Frequency

    Change From Baseline Upper Respiratory Illness Frequency at 6 months

  • Cognitive Function

    Change from Baseline Cognitive Function at 6 months

  • Falls Risk

    Change From Baseline Falls Efficacy and Frequency at 6 months

  • +1 more secondary outcomes

Study Arms (2)

Egg while protein supplement

EXPERIMENTAL

25 g of powdered egg white protein supplement daily for 6 months. Total of 20.6 g of protein in 25 g of supplement.

Dietary Supplement: powdered egg white protein supplement

Maltodextrin supplement

PLACEBO COMPARATOR

25 g of powdered maltodextrin supplement daily for 6 months. Total 23.5 g of carbohydrate in 25 g of supplement.

Dietary Supplement: maltodextrin supplement

Interventions

consumption of egg white protein supplement daily for 6 months

Egg while protein supplement
maltodextrin supplementDIETARY_SUPPLEMENT

consumption of maltodextrin supplement daily for 6 months

Maltodextrin supplement

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older, gait speed \>0.8m/s OR hand grip below 20kg for women or below 30kg for men

You may not qualify if:

  • Over 300 pounds, kidney disease, has taken a protein supplement within the past 30 days, dementia/Alzheimer's, uncontrolled diabetes, wheelchair bound, vegan, allergic to eggs, blind/legally blind, history of stroke/transient ischemic attack with a Barthel score of 15 or lower, cannot read or write English or Spanish and don't have someone to help them with forms/paperwork, not willing to take a supplement for 6 months or will not remain in the local area for the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas at San Antonio

San Antonio, Texas, 78249, United States

Location

Related Publications (10)

  • Drewnowski A, Specter SE. Poverty and obesity: the role of energy density and energy costs. Am J Clin Nutr. 2004 Jan;79(1):6-16. doi: 10.1093/ajcn/79.1.6.

    PMID: 14684391BACKGROUND
  • Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.

    PMID: 20392703BACKGROUND
  • Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004 Jan;52(1):80-5. doi: 10.1111/j.1532-5415.2004.52014.x.

    PMID: 14687319BACKGROUND
  • Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review. Gerontology. 2014;60(4):294-305. doi: 10.1159/000356760. Epub 2014 Apr 8.

    PMID: 24731978BACKGROUND
  • Cruz-Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y, Chen LK, Fielding RA, Martin FC, Michel JP, Sieber C, Stout JR, Studenski SA, Vellas B, Woo J, Zamboni M, Cederholm T. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014 Nov;43(6):748-59. doi: 10.1093/ageing/afu115. Epub 2014 Sep 21.

    PMID: 25241753BACKGROUND
  • Best RL, Appleton KM. The consumption of protein-rich foods in older adults: an exploratory focus group study. J Nutr Educ Behav. 2013 Nov-Dec;45(6):751-5. doi: 10.1016/j.jneb.2013.03.008. Epub 2013 Jul 2.

    PMID: 23827439BACKGROUND
  • Paddon-Jones D, Rasmussen BB. Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):86-90. doi: 10.1097/MCO.0b013e32831cef8b.

    PMID: 19057193BACKGROUND
  • Lloyd JL, Wellman NS. Older Americans Act Nutrition Programs: A Community-Based Nutrition Program Helping Older Adults Remain at Home. J Nutr Gerontol Geriatr. 2015;34(2):90-109. doi: 10.1080/21551197.2015.1031592.

    PMID: 26106983BACKGROUND
  • Milne AC, Avenell A, Potter J. Meta-analysis: protein and energy supplementation in older people. Ann Intern Med. 2006 Jan 3;144(1):37-48. doi: 10.7326/0003-4819-144-1-200601030-00008.

    PMID: 16389253BACKGROUND
  • Ullevig SL, Zuniga K, Austin Lobitz C, Santoyo A, Yin Z. Egg protein supplementation improved upper body muscle strength and protein intake in community-dwelling older adult females who attended congregate meal sites or adult learning centers: A pilot randomized controlled trial. Nutr Health. 2022 Dec;28(4):611-620. doi: 10.1177/02601060211051592. Epub 2021 Nov 3.

Related Links

MeSH Terms

Conditions

Sarcopenia

Condition Hierarchy (Ancestors)

Muscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Sarah L Ullevig, PhD, RD

    University of Texas at San Antonio

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants will be blinded to control (carbohydrate) or egg white protein supplement
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 13, 2017

First Posted

May 21, 2018

Study Start

May 31, 2017

Primary Completion

August 31, 2018

Study Completion

August 31, 2018

Last Updated

December 20, 2024

Record last verified: 2020-11

Locations